Related Experiment Video
Updated: Jul 26, 2025

Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV
Published on: March 5, 2022
Deciphering glioma epitranscriptome: focus on RNA modifications
Christina Piperi1, Mariam Markouli2, Antonios N Gargalionis3
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece. cpiperi@med.uoa.gr.
Abstract:
Gliomas are highly malignant tumors accounting for the majority of brain neoplasms. They are characterized by nuclear atypia, high mitotic rate and cellular polymorphism that often contributes to aggressiveness and resistance to standard therapy. They often associate with challenging treatment approaches and poor outcomes. New treatment strategies or regimens to improve the efficacy of glioma treatment require a deeper understanding of glioma occurrence and development as well as elucidation of their molecular biological characteristics. Recent studies have revealed RNA modifications as a key regulatory mechanism involved in tumorigenesis, tumor progression, immune regulation, and response to therapy. The present review discusses research advances on several RNA modifications involved in glioma progression and tumor microenvironment (TME) immunoregulation as well as in the development of adaptive drug resistance, summarizing current progress on major RNA modification targeting strategies.
Insights
RNA modifications are crucial in glioma development and treatment resistance. Understanding these changes offers new therapeutic strategies for brain tumors.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Gliomas are aggressive brain tumors with poor treatment outcomes.
- Standard therapies often face challenges due to tumor aggressiveness and resistance.
- Understanding glioma biology is key to developing effective treatments.
Purpose of the Study:
- To review RNA modifications in glioma progression and tumor microenvironment (TME) immunoregulation.
- To summarize advances in targeting RNA modifications for glioma therapy.
- To explore the role of RNA modifications in adaptive drug resistance.
Main Methods:
- Literature review of recent studies on RNA modifications in gliomas.
- Analysis of research on RNA modification targeting strategies.
- Synthesis of information on TME immunoregulation and drug resistance.
Main Results:
- RNA modifications play a significant role in glioma tumorigenesis and progression.
- Specific RNA modifications influence tumor microenvironment immunoregulation.
- These modifications are implicated in the development of adaptive drug resistance.
Conclusions:
- Targeting RNA modifications presents a promising avenue for novel glioma therapies.
- Further research into RNA modification mechanisms can improve treatment efficacy.
- Understanding these molecular mechanisms is vital for overcoming therapeutic challenges.
Related Concept Videos
RNA Editing
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Regulated mRNA Transport
Leaky Scanning
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
MicroRNAs

